Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

New Serratane Triterpenoid and Musashi2 inhibitors from Huperzia serrata.

Planta medica·2026

Same author

Exploring the link between intravoxel incoherent motion measured brain diffusivity during wakefulness and sleep macrostructure in the elderly.

NeuroImage·2026

Same author

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.

Nature medicine·2026

Same author

Compensatory Intercellular Mitochondrial Transfer Improves Bioenergetics in P301L Tau-Affected Neuronal Cells.

Cells·2026

Same author

Structural Connectivity of Functionally Defined Episodic Memory Networks: A Large-Scale Connectome-Behavior Study.

Brain and behavior·2026

Same author

Mendelian Randomization Identifies Lipidomic Signatures of Depression Risk That Are Partly Reflected in Cortisol-Induced Membrane Remodeling and Modulated by St. John's Wort Extract (Ze 117).

International journal of molecular sciences·2026

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers.

Christian R A Mondadori¹, Dominique J-F de Quervain, Andreas Buchmann

¹Division of Psychiatry Research, University of Zurich, 8032 Zurich, Switzerland.

Cerebral Cortex (New York, N.Y. : 1991)

|November 2, 2006

Summary

The apolipoprotein E (APOE) epsilon4 allele is linked to better episodic memory in young adults. APOE epsilon4 carriers show reduced brain activity during learning and retrieval, suggesting efficient neural resource use.

More Related Videos

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Direct Cryosectioning of Drosophila Heads for Enhanced Brain Fluorescence Staining and Immunostaining

Direct Cryosectioning of Drosophila Heads for Enhanced Brain Fluorescence Staining and Immunostaining

Published on: February 7, 2025

Related Experiment Videos

Last Updated: Jul 19, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Direct Cryosectioning of Drosophila Heads for Enhanced Brain Fluorescence Staining and Immunostaining

Direct Cryosectioning of Drosophila Heads for Enhanced Brain Fluorescence Staining and Immunostaining

Published on: February 7, 2025

Area of Science:

Neuroscience
Genetics
Cognitive Psychology

Background:

The apolipoprotein E (APOE) epsilon4 allele is a primary genetic risk factor for Alzheimer's disease.
The impact of APOE isoforms on memory and neurophysiology in healthy young individuals remains unclear.

Purpose of the Study:

To investigate the association between APOE genotype and episodic memory performance in young, healthy adults.
To examine the effects of APOE isoforms on memory-related brain activity using neuroimaging.

Main Methods:

Episodic memory performance was assessed in 340 young, healthy participants with known APOE genotypes (epsilon2, epsilon3, epsilon4).
Neuroimaging (fMRI) was conducted on a subset of 34 memory-matched individuals during learning and retrieval tasks.
Brain activity patterns were analyzed in relation to APOE genotype and memory performance.

Main Results:

APOE epsilon4 carriers demonstrated superior episodic memory performance compared to APOE epsilon2 and epsilon3 carriers.
During learning, epsilon4 carriers showed decreased brain activity, while epsilon2 and epsilon3 carriers exhibited increased activity.
During retrieval, epsilon4 carriers displayed reduced neural activity despite equivalent retrieval performance, indicating efficient neural resource utilization.

Conclusions:

The APOE epsilon4 allele is associated with enhanced episodic memory in young, healthy individuals.
APOE epsilon4 carriers utilize neural resources more economically during memory encoding and retrieval.
These findings suggest a distinct neurobiological profile associated with the APOE epsilon4 allele in the absence of cognitive impairment.